Good and bad consequences of altered fatty acid metabolism in heart failure: evidence from mouse models

Desiree Abdurrachim, Joost J. F. P. Luiken, Klaas Nicolay, Jan F. C. Glatz, Jeanine J. Prompers, Miranda Nabben*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

65 Citations (Web of Science)
32 Downloads (Pure)


The shift in substrate preference away from fatty acid oxidation (FAO) towards increased glucose utilization in heart failure has long been interpreted as an oxygen-sparing mechanism. Inhibition of FAO has therefore evolved as an accepted approach to treat heart failure. However, recent data indicate that increased reliance on glucose might be detrimental rather than beneficial for the failing heart. This review discusses new insights into metabolic adaptations in heart failure. A particular focus lies on data obtained from mouse models with modulations of cardiac FA metabolism at different levels of the FA metabolic pathway and how these differently affect cardiac function. Based on studies in which these mouse models were exposed to ischaemic and non-ischaemic heart failure, we discuss whether and when modulations in FA metabolism are protective against heart failure.
Original languageEnglish
Pages (from-to)194-205
JournalCardiovascular Research
Issue number2
Publication statusPublished - 1 May 2015


  • Heart failure
  • Energy metabolism
  • Genetically altered mice
  • Metabolic shift

Cite this